Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning a Method and Device for Detection of Bioavailable Drug Concentration in a Fluid Sample
---
identifier: "/us/fr/2012-649"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning a Method and Device for Detection of Bioavailable Drug Concentration in a Fluid Sample"
title_number: 0
title_name: "Federal Register"
section_number: "2012-649"
section_name: "Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning a Method and Device for Detection of Bioavailable Drug Concentration in a Fluid Sample"
positive_law: false
currency: "2012-01-17"
last_updated: "2012-01-17"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Defense Department"
document_number: "2012-649"
document_type: "notice"
publication_date: "2012-01-17"
agencies:
- "Defense Department"
- "Army Department"
fr_citation: "77 FR 2278"
fr_volume: 77
fr_action: "Notice; correction."
---
# Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning a Method and Device for Detection of Bioavailable Drug Concentration in a Fluid Sample
**AGENCY:**
Department of the Army, DOD.
**ACTION:**
Notice; correction.
**SUMMARY:**
The notice published in the *Federal Register* on January 6, 2012 (77 FR 783) contained an incorrect U.S. Provisional Patent Application Serial No. The correct number is 61/105,604.
**FOR FURTHER INFORMATION CONTACT:**
For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619-6664, both at telefax (301) 619-5034.
Brenda S. Bowen,
Army Federal Register Liaison Officer.